7 Indian American healthcare trailblazers claim national oncology honors

🩺🇮🇳 Seven healthcare innovators of Indian origin have been named to the Association for Value-Based Cancer Care’s prestigious 2026 “40 Under 40 in Cancer” list, recognizing their groundbreaking contributions to oncology, patient care, medical research, mental health, and healthcare innovation across the United States. Chosen from nearly 2,800 nominees nationwide, the honorees are helping reshape modern cancer treatment through clinical leadership, digital education, pharmaceutical research, and patient-focused care models.

Among the standout names are Dr. Vishnukamal Golla, who works on reducing the financial and structural burden of cancer care, and Dr. Puneeth Indurlal, who is helping design payment systems aimed at making life-saving cancer treatments more affordable and accessible. Dr. Sundeep Grandhe is advancing culturally responsive palliative medicine, while Dr. Milan Thakor is pioneering mental health support systems for cancer patients and caregivers facing emotional trauma during treatment journeys.

The list also includes globally recognized voices in oncology innovation. Dr. Sanjay Juneja has built a massive digital education platform simplifying cancer knowledge for over half a million people worldwide, while Dr. Paul Singh leads critical multiple myeloma research and clinical strategies at AstraZeneca. Dr. Urvi Shah of Memorial Sloan Kettering Cancer Center is gaining national attention for exploring how nutrition and metabolic health can improve survival outcomes for cancer patients.

The recognition highlights the growing influence of Indian-origin physicians and researchers in transforming America’s healthcare system through innovation, compassion, and cutting-edge medical science. The honorees will be formally celebrated during a special ceremony in Chicago later this month. 🌍🎓💙